Pharmafile Logo
Pharmafocus logo
Advanced Search
Novo image

Novo Nordisk opens insulin plant in Russia

April 10, 2015
Manufacturing and Production, Sales and Marketing Novo Nordisk, Russia, diabetes, flexpen, insulin, kaluga, penfill

Denmark’s Novo Nordisk has opened a new manufacturing facility in Russia to produce more of its diabetes offerings in the …

News
Pfizer image

Pfizer launches cardiovascular research competition

April 10, 2015
Research and Development, Sales and Marketing Amgen, Astellas, LDL, PCSK9, Pfizer, bococizumab, inhibitors

Pfizer is funding a new competitive grants programme to support research projects in the burgeoning, competitive area of cholesterol-lowering PCSK9 …

News
Eisai image

Eisai cuts 25% of US staff

April 10, 2015
Medical Communications, Research and Development, Sales and Marketing Daiichi, Eisai, US, cuts, layoffs, reorganisation, staff

Eisai’s US business is offloading around 200 jobs as part of some restructuring to create a more ‘efficient and focussed …

News
Shire image

Shire gets FDA boost – but suffers trial setback

April 10, 2015
Research and Development, Sales and Marketing FDA, Shire, algs, lifitegrast, shp625

Shire has achieved mixed results in its attempts to get regulatory approval for two new treatments – bagging a priority …

News
kris_richards_1

RSA hires senior consultant

April 10, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kris Richards, rsa

Life sciences executive search and interims specialist firm RSA has appointed a new senior consultant to its executive interims team. …

Appointment

Over one billion drugs dispensed in England in 2014, NHS report shows

April 9, 2015
Sales and Marketing HSCIC, NHS, drug cost, net ingredient cost, prescribing, prescription cost analysis, prescriptions

Patients in England collected over 1.1 billion prescription items in 2014, according to NHS figures. Statistics from the Health and …

News
Perrigo image

Mylan in huge $29 billion bid for Perrigo

April 9, 2015
Abbott, Mylan, OTC, Perrigo, Shire

Mylan has offered to pay the over-the-counter (OTC) drug specialist Perrigo $28 billion to acquire its business. The proposed deal …

News
xalkori

Merck and Pfizer to co-promote cancer drug

April 9, 2015
Research and Development, Sales and Marketing Cancer, Merck, Merck KGaA, NSCLC, Pfizer, Xalkori, non-small cell lung cancer, oncology

Merck KgaA and Pfizer have agreed to co-promote the latter’s lung cancer treatment Xalkori, and form a new alliance that …

News
margaret_hamburg

Former FDA commissioner named as Institute of Medicine foreign secretary

April 9, 2015
Manufacturing and Production, Medical Communications, Research and Development Dr Margaret Hamburg, FDA, IOM, Institute of Medicine, Margaret Hamburg

Former commissioner of the US Food and Drug Administration Margaret Hamburg has been appointed as the next foreign secretary of …

Appointment
beverly_hope_cello

Cello Health Consulting gains senior marketer

April 8, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cello, beverly hope, consulting, health

Healthcare strategic marketing consultancy Cello Health Consulting has appointed pharma marketer Beverly Hope as a senior consultant for its brand and portfolio …

Appointment
Gilead image

Gilead’s next-generation HIV drug to be FDA assessed

April 8, 2015
Research and Development, Sales and Marketing F/TAF, FDA, Gilead, HIV, Tenofovir Alafenamide, emtricitabine

Gilead Sciences has filed its second new drug application for a new combination HIV treatment with the FDA.The California-based company …

News
Amgen image

Amgen’s colorectal cancer drug EU approved

April 8, 2015
Sales and Marketing Amgen, Vectibix, ibrutinib, imbruvica, panitumumab, ristempa

The European Commission has shown Amgen’s cancer drug Vectibix the green light to treat patients in combination with chemotherapy for …

News
Novo image

FDA to look again at Novo Nordisk insulin submissions

April 8, 2015
Research and Development, Sales and Marketing Novo Nordisk, Ryzodeg, Tresiba, diabetes, insulin degludec

Diabetes specialist firm Novo Nordisk has resubmitted its applications for two insulins to the FDA, along with new interim safety …

News
Avastin image

EU nod for Roche cancer drug and chemotherapy

April 8, 2015
Sales and Marketing Cancer, Roche, avastin, bevacizumab, cervical, chemotherapy, wet AMD

The European Commission has approved Roche’s Avastin in combination with standard chemotherapy for women with advanced cervical cancer.  Avastin (bevacizumab) …

News
konstantinos_kosmatopoulos

Vaxon Biotech appoints founder as chief executive

April 8, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Konstantinos Kosmatopoulos, vaxon biotech

Paris-based Vaxon Biotech has announced its founder Dr Konstantinos Kosmatopoulos is moving from his current role as chief scientific officer …

Appointment
Dubai skyline

Takeda expands in the United Arab Emirates

April 7, 2015
Medical Communications, Sales and Marketing Dubai, NEMEA, Singapore, Takeda, UAE, United Arab Emirates, near east

Takeda has opened new UAE offices in Dubai amidst plans to expand its business in the Middle East. The Japanese …

News

Antibiotic resistance outbreak ‘could kill 80,000’, report warns

April 7, 2015
Research and Development, Sales and Marketing AMR, Nabriva Therapeutics, antibiotic resistance, bacteria, blood infections, infections

An antibiotic-resistant blood infection outbreak could lead to 80,000 deaths, according to a government report on threats to the UK. …

News

Hundreds of jobs threatened after big pharma deals close

April 7, 2015
Medical Communications, Research and Development, Sales and Marketing Deals, GSK, Jobs, Novartis, US, Valeant, job losses, redundancy, salix

Fresh from deals worth a combined $34 billion, GSK and Salix Pharmaceuticals have announced company restructures that have placed more …

News
Market access means new drugs are available to prescribe to patients

Refining UK market access

April 7, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, UK, health, market access

“Some people have said NICE needs to change, it needs to create a new vision, but we say we need …

Feature
BMS image

BMS enters gene therapy development deal

April 7, 2015
Research and Development BMS, Bristol-Myers Squibb, R&D, cardiovascular disease, cvd, heart disease, heart failure, uniQure

Bristol-Myers Squibb (BMS) has signed a multi-million dollar agreement with Amsterdam-based gene therapy firm uniQure to boost research into new …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026